...
首页> 外文期刊>Expert opinion on therapeutic targets >Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy
【24h】

Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy

机译:受体酪氨酸激酶样孤儿受体1:癌症免疫治疗的新目标

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is a member of the receptor tyrosine kinase family. ROR1 is selectively overexpressed in a number of solid and hematological malignancies without significant expression in normal adult tissues. There are also some lines of evidence, which support the critical role of ROR1 in tumorigenesis. These characteristics introduce ROR1 as a suitable target for selective cancer immunotherapy. ROR1 targeting using different approaches such as siRNA, tyrosine kinase inhibitors and antibody induces tumor growth suppression in cancer cells.
机译:简介:受体酪氨酸激酶样孤儿受体1(ROR1)是受体酪氨酸激酶家族的成员。 ROR1在许多实体和血液系统恶性肿瘤中选择性过表达,而在正常成人组织中无明显表达。也有一些证据支持ROR1在肿瘤发生中的关键作用。这些特征使ROR1成为选择性癌症免疫疗法的合适靶标。使用不同的方法(例如siRNA,酪氨酸激酶抑制剂和抗体)靶向ROR1可诱导癌细胞中的肿瘤生长抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号